Hualan Biological Engineering Inc. (SHE:002007)
China flag China · Delayed Price · Currency is CNY
14.46
+0.04 (0.28%)
May 6, 2026, 3:04 PM CST

SHE:002007 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
885.23774.811,367993.771,099692.54
Short-Term Investments
184.791,0052,1441,213240-
Trading Asset Securities
2,6972,6231,8882,1152,3692,659
Cash & Short-Term Investments
3,7674,4035,3984,3223,7083,352
Cash Growth
-37.57%-18.44%24.90%16.56%10.63%-16.72%
Accounts Receivable
2,1142,0782,0522,5902,4102,097
Other Receivables
0.736.0918.666.954.847.05
Receivables
2,1142,0842,0713,2972,7592,104
Inventory
2,5402,2892,0291,6741,4471,359
Other Current Assets
281.9983.78118.4633.7163.5636.67
Total Current Assets
8,7038,8599,6169,3278,0776,851
Property, Plant & Equipment
2,9732,9822,9642,7272,2902,338
Long-Term Investments
124.962,7843,0233,2733,6731,716
Goodwill
---1.11.11.1
Other Intangible Assets
310.88314.13319.04319.72310204.53
Long-Term Deferred Tax Assets
196.66196.85235.34241.72232.49201.25
Long-Term Deferred Charges
54.355.3159.6959.642.4955.42
Other Long-Term Assets
2,69669.7992.74157.3116.8170.16
Total Assets
15,05915,26216,31016,10614,74311,537
Accounts Payable
218.73196.26217.16197.26175.49241.03
Accrued Expenses
0.53926.54914.991,1691,071947.5
Short-Term Debt
-447899.73700.35800.38800.7
Current Portion of Long-Term Debt
---300-10.18
Current Portion of Leases
0.390.390.370.360.44-
Current Income Taxes Payable
35.3618.1419.5863.369.748.71
Current Unearned Revenue
6.3210.2113.468.5714.788.28
Other Current Liabilities
1,063196.78294.83142.376.53158.53
Total Current Liabilities
1,3241,7952,3602,5812,1482,215
Long-Term Debt
----300190
Long-Term Leases
8.488.398.789.159.3-
Long-Term Unearned Revenue
66.1859.4654.1851.1854.3757.91
Long-Term Deferred Tax Liabilities
26.358.1140.1442.8220.8710.37
Total Liabilities
1,4251,8712,4632,6852,5332,473
Common Stock
1,8271,8271,8291,8291,8241,824
Additional Paid-In Capital
1,3871,3971,4301,4861,415105.62
Retained Earnings
8,5248,2948,6338,0937,1596,448
Treasury Stock
-17.95-17.95-32.72-48.07--40.59
Total Common Equity
11,72011,50111,85911,35910,3988,337
Minority Interest
1,9131,8901,9882,0621,812727.09
Shareholders' Equity
13,63413,39113,84713,42112,2109,064
Total Liabilities & Equity
15,05915,26216,31016,10614,74311,537
Total Debt
8.87455.78908.881,0101,1101,001
Net Cash (Debt)
3,7583,9474,4893,3122,5982,351
Net Cash Growth
-24.02%-12.07%35.54%27.50%10.51%-35.14%
Net Cash Per Share
2.062.162.461.821.421.28
Filing Date Shares Outstanding
1,8271,8271,8291,8291,8241,824
Total Common Shares Outstanding
1,8271,8271,8291,8291,8241,824
Working Capital
7,3797,0647,2566,7455,9294,636
Book Value Per Share
6.416.296.486.215.704.57
Tangible Book Value
11,40911,18611,54011,03910,0878,131
Tangible Book Value Per Share
6.246.126.316.045.534.46
Buildings
-1,8081,7171,3021,2061,256
Machinery
-2,7142,6392,5042,3832,433
Construction In Progress
-643.37552.48661.51216.39132.96
Source: S&P Global Market Intelligence. Standard template. Financial Sources.